Evaluated by: David B. Kaminsky, M.D., FIAC, March 21, 2018
Original release date: May 29, 2018
Access to this course expires on: March 21, 2021
Faculty: Jan F. Silverman, M.D.
- Recognize that adenocarcinoma constitutes the majority of metastatic malignancies of unknown primary
- Recognize the value of immunohistochemistry to separate basaloid squamous cell carcinoma from small cell carcinoma
- Recognize that the most common sarcomatous appearing malignancy presenting as a met of unknown primary is a sarcomatoid carcinoma rather than a scarcoma.
$59.00 - $79.00